Results 271 to 280 of about 9,188,168 (301)
Some of the next articles are maybe not open access.
Estrogen and the Risk of Breast Cancer
New England Journal of Medicine, 2001The connection between breast cancer and estrogen has been recognized for more than 100 years, since George Beatson demonstrated that bilateral oophorectomy resulted in the remission of breast cancer in premenopausal women.1 Subsequent evidence has implicated both endogenous and exogenous estrogen in the pathogenesis of breast cancer.
M, Clemons, P, Goss
openaire +2 more sources
Pregnancy and the risk of breast cancer
Endocrine Related Cancer, 2007It is well established that childless women and women having children later in life are at an increased risk of developing breast cancer. In particular, women having a first child before 20 years of age have a 50% reduction in lifetime breast cancer risk when compared with women who do not have children.
Kara, Britt +2 more
openaire +2 more sources
Benzodiazepines and Risk for Breast Cancer
Annals of Epidemiology, 2006The study aim is to evaluate benzodiazepine use and risk for breast cancer in Ontario, Canada, by using a population-based case-control study design.Cases were a random sample of women aged 25 to 74 years identified through the Ontario Cancer Registry and diagnosed with breast cancer between 1996 and 1998 (n = 3133). Controls were an age-matched random
Erika, Halapy +3 more
openaire +2 more sources
Lactation and Breast Cancer Risk
Journal of Mammary Gland Biology and Neoplasia, 1997Breast cancer is a common disease with few practical preventive measures. The recent evidence that lactation, like other reproductive experiences, is associated with a modest reduction in breast cancer risk is therefore of great interest. Overall, the reduction in risk appears to be about 20% for ever breast feeding and is even greater for women with ...
openaire +2 more sources
Resveratrol and breast cancer risk
European Journal of Cancer Prevention, 2005Resveratrol is a non-flavonoid polyphenol that has attracted attention as a potential anticancer agent in vitro and in vivo, but scanty epidemiological data are available. We have therefore analysed the relation between dietary intake of resveratrol and breast cancer risk using data from a case-control study conducted between 1993 and 2003 in the Swiss
F. Levi +5 more
openaire +3 more sources
Fertility and Sterility, 2003
Two large recent studies indicate an increased risk of breast cancer with use of menopausal hormone therapy (HT), particularly combinations of estrogen and progestogen. These studies also go against previous theories of the types of breast cancer that would be associated with HT use.
Michelle L, Geller, Rowan T, Chlebowski
openaire +2 more sources
Two large recent studies indicate an increased risk of breast cancer with use of menopausal hormone therapy (HT), particularly combinations of estrogen and progestogen. These studies also go against previous theories of the types of breast cancer that would be associated with HT use.
Michelle L, Geller, Rowan T, Chlebowski
openaire +2 more sources
Menopause and the Risk of Breast Cancer
Annals of the New York Academy of Sciences, 1990In summary, although there is a fair amount of inconsistency regarding the effects of menopausal estrogen therapy on the risk of breast cancer, this may relate to inability of some studies to fully assess effects related to long-term and/or high-dosage usage, the exposures that appear to be most consistently related to elevations in breast cancer risk.
openaire +2 more sources
Breast Cancer Recurrence Risk Can Remain for 10 to 32 Years
Ca-A Cancer Journal for Clinicians, 2022Mike Fillon
exaly